{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T06:41:46Z","timestamp":1774939306216,"version":"3.50.1"},"reference-count":26,"publisher":"Oxford University Press (OUP)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,7,1]]},"DOI":"10.1093\/humrep\/dei004","type":"journal-article","created":{"date-parts":[[2005,4,1]],"date-time":"2005-04-01T01:24:02Z","timestamp":1112318642000},"page":"1833-1836","source":"Crossref","is-referenced-by-count":50,"title":["Absence of hepatotoxicity after long-term, low-dose flutamide in hyperandrogenic girls and young women"],"prefix":"10.1093","volume":"20","author":[{"given":"Lourdes","family":"Ib\u00e1\u00f1ez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriana","family":"Jaramillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Ferrer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francis","family":"de Zegher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2005,3,31]]},"reference":[{"key":"key\n\t\t\t\t20171011160407_R1","doi-asserted-by":"crossref","unstructured":"Andrade RJ, Lucena MI, Fernandez MC, Suarez F, Montero JL, Fraga E and Hidalgo F (1999) Fulminant liver failure associated with flutamide therapy for hirsutism. Lancet353, 983.","DOI":"10.1016\/S0140-6736(99)00564-4"},{"key":"key\n\t\t\t\t20171011160407_R2","doi-asserted-by":"crossref","unstructured":"Ferriman D and Gallwey JD (1961) Clinical assessment of body hair growth in women. J Clin Endocrinol Metab21, 1440\u20131447.","DOI":"10.1210\/jcem-21-11-1440"},{"key":"key\n\t\t\t\t20171011160407_R3","doi-asserted-by":"crossref","unstructured":"Gomez JL, Dupont A, Cusan L, Tremblay M, Suburu R, Lemay M and Labrie F (1992) Incidence of liver toxicity associated with the use of flutamide in prostate cancer patients. Am J Med92, 465\u2013470.","DOI":"10.1016\/0002-9343(92)90741-S"},{"key":"key\n\t\t\t\t20171011160407_R4","doi-asserted-by":"crossref","unstructured":"Ib\u00e1\u00f1ez L and de Zegher F (2003a) Flutamide-metformin to reduce fat mass in hyper-insulinemic ovarian hyperandrogenism: effects in adolescents and in women on third-generation oral contraception. J Clin Endocrinol Metab88, 4720\u20134724.","DOI":"10.1210\/jc.2003-030117"},{"key":"key\n\t\t\t\t20171011160407_R5","doi-asserted-by":"crossref","unstructured":"Iba\u00f1ez L and de Zegher F (2003b) Low-dose combination of flutamide, metformin and an oral contraceptive for non-obese, young women with polycystic ovary syndrome. Hum Reprod18, 57\u201360.","DOI":"10.1093\/humrep\/deg056"},{"key":"key\n\t\t\t\t20171011160407_R6","doi-asserted-by":"crossref","unstructured":"Ib\u00e1\u00f1ez L and de Zegher F (2004) Ethinylestradiol\u2013drospirenone, flutamide\u2013metformin, or both for adolescents and young women with hyperinsulinemic hyperandrogenism: opposite effects on adipocytokines and body adiposity. J Clin Endocrinol Metab89, 1592\u20131597.","DOI":"10.1210\/jc.2003-031281"},{"key":"key\n\t\t\t\t20171011160407_R7","doi-asserted-by":"crossref","unstructured":"Ib\u00e1\u00f1ez L and de Zegher F (2005) Flutamide\u2013metformin plus ethinylestradiol\u2013drospirenone for lipolysis and anti-atherogenesis in young women with ovarian hyperandrogenism: the key role of metformin at the start and after more than one year of therapy. J Clin Endocrinol Metab90, 39\u201343.","DOI":"10.1210\/jc.2004-1405"},{"key":"key\n\t\t\t\t20171011160407_R8","doi-asserted-by":"crossref","unstructured":"Ib\u00e1\u00f1ez L, Potau N, Zampolli M, Riqu\u00e9 S, Saenger P and Carrascosa A (1997) Hyperinsulinemia and decreased insulin-like growth factor binding protein-1 are common features in prepubertal and pubertal girls with a history of premature pubarche. J Clin Endocrinol Metab82, 2283\u20132288.","DOI":"10.1210\/jcem.82.7.4084"},{"key":"key\n\t\t\t\t20171011160407_R9","doi-asserted-by":"crossref","unstructured":"Iba\u00f1ez L, Potau N, Marcos MV and de Zegher F (2000) Treatment of hirsutism, hyperandrogenism, oligomenorrhea, dyslipidemia, and hyperinsulinism in nonobese, adolescent girls: effect of flutamide. J Clin Endocrinol Metab85, 3251\u20133255.","DOI":"10.1210\/jcem.85.9.6814"},{"key":"key\n\t\t\t\t20171011160407_R10","doi-asserted-by":"crossref","unstructured":"Ib\u00e1\u00f1ez L, Valls C, Potau N, Marcos MV and de Zegher F (2001) Polycystic ovary syndrome after precocious pubarche: ontogeny of the low birthweight effect. Clin Endocrinol55, 667\u2013672.","DOI":"10.1046\/j.1365-2265.2001.01399.x"},{"key":"key\n\t\t\t\t20171011160407_R11","doi-asserted-by":"crossref","unstructured":"Iba\u00f1ez L, Valls C, Ferrer A, Ong K, Dunger DB and De Zegher F (2002) Additive effects of insulin-sensitizing and anti-androgen treatment in young, nonobese women with hyperinsulinism, hyperandrogenism, dyslipidemia, and anovulation. J Clin Endocrinol Metab87, 2870\u20132874.","DOI":"10.1210\/jcem.87.6.8568"},{"key":"key\n\t\t\t\t20171011160407_R12","doi-asserted-by":"crossref","unstructured":"Iba\u00f1ez L, Ong K, Ferrer A, Amin R, Dunger D and de Zegher F (2003) Low-dose flutamide\u2013metformin therapy reverses insulin resistance and reduces fat mass in nonobese adolescents with ovarian hyperandrogenism. J Clin Endocrinol Metab88, 2600\u20132606.","DOI":"10.1210\/jc.2002-022002"},{"key":"key\n\t\t\t\t20171011160407_R13","doi-asserted-by":"crossref","unstructured":"Ib\u00e1\u00f1ez L, Valls C, Cabr\u00e9 S and de Zegher F (2004a) Flutamide\u2013metformin plus ethinylestradiol\u2013drospirenone for lipolysis and anti-atherogenesis in young women with ovarian hyperandrogenism: the key role of early, low-dose flutamide. J Clin Endocrinol Metab89, 4716\u20134720.","DOI":"10.1210\/jc.2004-0047"},{"key":"key\n\t\t\t\t20171011160407_R14","doi-asserted-by":"crossref","unstructured":"Ib\u00e1\u00f1ez L, Ferrer A, Ong K, Amin R, Dunger D and de Zegher F (2004b) Insulin sensitization early post-menarche prevents progression from precocious pubarche to polycystic ovary syndrome. J Pediatr144, 23\u201329.","DOI":"10.1016\/j.jpeds.2003.08.015"},{"key":"key\n\t\t\t\t20171011160407_R15","unstructured":"Labrie F, Dupont A, Giguere M, Borsanyi JP, Lacourciere Y, Belanger A, Lachance R, Emond J and Monfette G (1988) Combination therapy with flutamide and castration (orchiectomy or LHRH agonist): the minimal endocrine therapy in both untreated and previously treated patients with advanced prostate cancer. Prog Clin Biol Res260, 41\u201362."},{"key":"key\n\t\t\t\t20171011160407_R16","doi-asserted-by":"crossref","unstructured":"Muderris II, Bayram F and Guven M (2000) Treatment of hirsutism with lowest-dose flutamide (62.5\u2009mg\/day). Gynecol Endocrinol14, 38\u201341.","DOI":"10.3109\/09513590009167658"},{"key":"key\n\t\t\t\t20171011160407_R17","doi-asserted-by":"crossref","unstructured":"New MI, Lorenzen F, Lerner AJ, Kohn B, Oberfield SE, Pollack MS, Dupont B, Stoner E, Levy DJ, Pang S and Levine LS (1983) Genotyping steroid 21-hydroxylase deficiency: hormonal reference data. J Clin Endocrinol Metab56, 320\u2013325.","DOI":"10.1210\/jcem-57-2-320"},{"key":"key\n\t\t\t\t20171011160407_R18","unstructured":"Sakkal-Alkaddour H, Zhang L, Yang X, Chang YT, Kappy M and Slover RS (1996) Studies of 3\u03b2-hydroxysteroid dehydrogenase genes in infants and children manifesting premature pubarche and increased adrenocorticotropin-stimulated (\u03945-steroid levels. J Clin Endocrinol Metab81, 3961\u20133965."},{"key":"key\n\t\t\t\t20171011160407_R19","doi-asserted-by":"crossref","unstructured":"Singh SM, Gauthier S and Labrie F (2000) Androgen receptor antagonists (antiandrogens): structure\u2013activity relationships. Curr Med Chem7, 211\u2013247.","DOI":"10.2174\/0929867003375371"},{"key":"key\n\t\t\t\t20171011160407_R20","doi-asserted-by":"crossref","unstructured":"The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1997) Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care20, 1183\u20131197.","DOI":"10.2337\/diacare.20.7.1183"},{"key":"key\n\t\t\t\t20171011160407_R21","doi-asserted-by":"crossref","unstructured":"Thole Z, Manso G, Salgueiro E, Revuelta P and Hidalgo A (2004) Hepatotoxicity induced by antiandrogens: a review of the literature. Urol Int73, 289\u2013295.","DOI":"10.1159\/000081585"},{"key":"key\n\t\t\t\t20171011160407_R22","doi-asserted-by":"crossref","unstructured":"Venturoli S, Paradisi R, Bagnoli A, Colombo FM, Ravaioli B, Vianello F, Mancini F, Gualerzi B, Porcu E and Seracchioli R (2001) Low-dose flutamide (125\u2009mg\/day) as maintenance therapy in the treatment of hirsutism. Horm Res56, 25\u201331.","DOI":"10.1159\/000048086"},{"key":"key\n\t\t\t\t20171011160407_R23","unstructured":"Vidal-Puig A and Moller DE (1997) Insulin resistance: Classification, prevalence, clinical manifestations, and diagnosis. In Azziz R, Nestler JE, and Dewailly D (eds) Androgen Excess Disorders in Women. Lippincott\u2013Raven Publishers, Philadelphia, USA, pp. 227\u2013236."},{"key":"key\n\t\t\t\t20171011160407_R24","doi-asserted-by":"crossref","unstructured":"Wallace C, Lalor EA and Chik CL (1993) Hepatotoxicity complicating flutamide treatment of hirsutism. Ann Intern Med119, 1150.","DOI":"10.7326\/0003-4819-119-11-199312010-00020"},{"key":"key\n\t\t\t\t20171011160407_R25","doi-asserted-by":"crossref","unstructured":"Wysowski DK and Fourcroy JL (1996) Flutamide hepatotoxicity. J Urol155, 209\u2013212.","DOI":"10.1016\/S0022-5347(01)66596-0"},{"key":"key\n\t\t\t\t20171011160407_R26","doi-asserted-by":"crossref","unstructured":"Wysowski DK, Freiman JP, Tourtelot JB and Horton ML, 3rd (1993) Fatal and nonfatal hepatotoxicity associated with flutamide. Ann Intern Med118, 860\u2013864.","DOI":"10.7326\/0003-4819-118-11-199306010-00006"}],"container-title":["Human Reproduction"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/humrep\/article-pdf\/20\/7\/1833\/6953504\/dei004.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,6]],"date-time":"2020-04-06T15:50:40Z","timestamp":1586188240000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/humrep\/article\/20\/7\/1833\/2356686\/Absence-of-hepatotoxicity-after-longterm-lowdose"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3,31]]},"references-count":26,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2005,3,31]]},"published-print":{"date-parts":[[2005,7,1]]}},"URL":"https:\/\/doi.org\/10.1093\/humrep\/dei004","relation":{},"ISSN":["1460-2350","0268-1161"],"issn-type":[{"value":"1460-2350","type":"electronic"},{"value":"0268-1161","type":"print"}],"subject":[],"published-other":{"date-parts":[[2005,7]]},"published":{"date-parts":[[2005,3,31]]}}}